Clinical value of serum carbohydrate antigen 125,human epididymal secretion protein 4 and ovarian cancer risk prediction index in the early diagnosis of ovarian cancer
XU Mei-mei1CHEN Ting-jian2FANG Li-shan3
1.Department of Inspection,Affiliated Hospital of Putian College,Fujian Province,Putian 351100,China;
2.Department of Respiratory Medicine,Affiliated Hospital of Putian College,Fujian Province,Putian 351100,China;
3.Department of Obstetrics and Gynecology,Affiliated Hospital of Putian College,Fujian Province,Putian 351100,China
Abstract：Objective To explore the clinical value of serum carbohydrate antigen 125(CA125),human epididymal secretion protein 4 (HE4)and ovarian cancer risk prediction index (ROMA)in the early diagnosis of ovarian cancer.Methods A total of 50 cases of ovarian cancer,50 cases of benign ovarian lesions and 50 cases of healthy physical examination were selected as study objects from February 2017 to July 2018 in our hospital.Serum HE4 and CA125 in the 3 groups were tested by electrochemical luminescence method and their ROMA were calculated for dynamic comparison.The clinical value of single and combined detection in early diagnosis of ovarian cancer was evaluated.Results HE4 and CA125 and ROMA in ovarian cancer group were significantly higher than those in benign ovarian tumor group and healthy control group,and the differences were statistically significant(P＜0.05).The differences of HE4,CA125 and ROMA between the benign ovarian tumor group and the healthy control group were not statistically significant(P＞0.05).Combined detection of HE4,CA125 and ROMA indec had a significant advantage in diagnosing ovarian cancer.Conclusion Combined detection of HE4 and CA125 and ROMA index has important clinical value in early diagnosis of ovary.
徐美妹; 陈挺剑;方丽珊. 血清糖类抗原125、人附睾上皮分泌蛋白4和卵巢癌风险预测指数联合检测在卵巢癌早期诊断中的临床价值[J]. 中国当代医药, 2019, 26(3): 159-161.
XU Mei-mei1CHEN Ting-jian2FANG Li-shan3. Clinical value of serum carbohydrate antigen 125,human epididymal secretion protein 4 and ovarian cancer risk prediction index in the early diagnosis of ovarian cancer. 中国当代医药, 2019, 26(3): 159-161.
Kirchoff C，Habben I，Lvell R，et al.Amajor human epididymis-speciffic cDNA enciders a protein with sequence homologytoextracellularproteinaseinhibitors[J].BiolReprod，1991，45（2）：350-357.
[12]
Kristjansdottir B，Levan K，Partheen K，et al.Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancerr[J].Gynecol Oncol，2013，131（1）：52-58．
[13]
Montagnana M，Benati M，Danese E.Circulating biomarkers in epi-thelial ovarian cancer diagnosis:from present to future perspective[J].Ann Transl Med，2017，5（13）：276．
Guo J，Yu J，Song X，et al.Serum CA125，CA199 and CEA combined detection for epithelial ovarian cancer diagnosis:A meta analysis[J].Open Med（Wars），2017，12（6）：131-137．
[16]
Lee S，Choi S，Lee Y，et al.Role of human epididymis protein 4 inhemoresistance and prognosis of epithelial ovarian cancer[J].J Obstet Gynaecol Res，2017，43（1）：220-222．
[17]
Anastasi E，Capoccia D，Granato T，et al.Assessing the association between 25-OH vitamin D levels and ROMA score in a population of obese women[J].J Biol Regul Homeost Agents，2016，30（4）：1165-1171．
Terlikowska KM，Dobrzycka B，Witkowska AM，et al.Preop erative HE4，CA125 and ROMA in the differential diagnosis of benignand malignant adnexal masses[J].J Ovarian Res，2016，9（1）：43．
京公网安备 11010502046607号